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In microarray data analysis, each gene expression sample has thousands of genes and reducing such high dimensionality is useful for
both visualization and further clustering of samples. Traditional principal component analysis (PCA) is a commonly used method which
has problems. Nonnegative Matrix Factorization (NMF) is a new dimension reduction method. In this paper we compare NMF and
PCA for dimension reduction. The reduced data is used for visualization, and clustering analysis via k-means on 11 real gene expression
datasets. Before the clustering analysis, we apply NMF and PCA for reduction in visualization. The results on one leukemia dataset show
that NMF can discover natural clusters and clearly detect one mislabeled sample while PCA cannot. For clustering analysis via k-means,
NMF most typically outperforms PCA. Our results demonstrate the superiority of NMF over PCA in reducing microarray data.
 2007 Elsevier Inc. All rights reserved.
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Microarray data, or gene expression data, plays an
important role in understanding life [1]. Many topics
include revealing natural structures and identifying inter-
esting patterns in the underlying data, which is helpful to
understand gene function, gene regulation, cellular pro-
cesses, subtypes of cells, and so on. However, microarrays
always contain thousands of genes with relatively few sam-
ples/conditions. In gene expression sample analysis, it is
useful to reduce the data for visualization in 2-D or 3-D,
and necessary for further clustering and classiﬁcation [1].
Traditional principal component analysis (PCA) is a
commonly used method for reducing data for visualization
and clustering analysis [2]. However previous results show
that PCA seems not suitable for dimension reduction in
further clustering gene expression [3]. Recently Nonnega-
tive Matrix Factorization (NMF) has been proposed for1532-0464/$ - see front matter  2007 Elsevier Inc. All rights reserved.
doi:10.1016/j.jbi.2007.12.003
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makes the results of face images intuitive visually and inter-
pretable rationally [4]. Now NMF is starting to become
widely used in data analysis; e.g. see [5,6] for more informa-
tion and references therein.
In bioinformatics area, NMF has also been proven a
powerful method for microarray data analysis and protein
sequence analysis [7]. However, in [8] NMF is used for clus-
tering genes and in [9] a modiﬁed algorithm based on NMF
is used for the same task; in [10] NMF is used for protein
sequence recognition; in [11,12] NMF is only directly used
for clustering gene expression samples with compared to
hierarchical clustering and self-organizing maps; in [13]
NMF is used for biclustering of gene expression data.
There are no results directly comparing PCA and NMF
for reducing microarray data in visualization and cluster-
ing analysis. In this paper, we compare PCA and NMF
for dimension reduction of microarray gene expression
data in visualization and clustering of samples with k-
means method. Our experimental results show the
superiority of NMF over PCA on microarray data.
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we brieﬂy introduce NMF and PCA and discuss their dif-
ferences in microarray data analysis. After some experi-
mental results shown in Section 3, we conclude in Section
4.2. NMF vs PCA for Reducing Microarray Data
Generally speaking, given a microarray dataset with n
genes in m samples, there are two important aspects:
n >> m holds while m is usually smaller than one hundred,
and the expression value is always positive. In this section,
we ﬁrst introduce PCA and NMF, and then discuss their
diﬀerences in reducing microarray data.2.1. PCA
Here we recall basic theory for PCA and discuss two
methods for computing the principal components. See
book [2] for more details and recent introductory article
on PCA and SVD [14].
Let X ¼ ½x1 . . . xm denote a data set with m samples in
Rn. Further assume that all samples are zero mean, and this
can be done by subtracting the mean value from the sam-
ples, i.e. xi  xi  l where l ¼ 1m
Pm
i¼1xi. The empirical
covariance matrix of the sample set is
C ¼ 1
m
XX T: ð1Þ
And this can be written, according to single value decom-
position theorem, as
C ¼ UKUT ð2Þ
where K ¼ diagðk1; . . . ; knÞ is the diagonal matrix with or-
dered eigenvalues k1 P k2 P . . .P kn, and U ¼ ½u1 . . . un
is the matrix whose columns are corresponding eigenvec-
tors. For dimension reduction, we choose the ﬁrst
rðr < nÞ eigenvectors according to the ﬁrst largest r eigen-
values, and get the new feature vectors of one sample x as
z ¼ UTr ðx lÞ: ð3ÞTable 1
Preprocessing strategy of datasets
Dataset no. Dataset name Value of
Floor C
1 11_Tumors 100 1
2 14_Tumors 100 1
3 9_Tumors 100 1
4 Brain_Tumor1 20 1
5 Brain_Tumor2 20 1
6 Leukemia1 20 1
7 Leukemia2 100 1
8 Lung_Cancer 0 N
9 SRBCT N N
10 Prostate_Tumor 20 1
11 DLBCL 20 1
‘N’ means no operation on the corresponding index.However, if m > n, it is time-consuming to get the eigenvec-
tors ui from the large empirical covariance matrix. One
alternative way [14] is to ﬁrst calculate the inner product
matrix
S ¼ 1
m
X TX ; ð4Þ
and it can be decomposed as
S ¼ V K0V T ð5Þ
where K0 ¼ diagðk01 P k02 P . . .P k0mÞ is the diagonal ma-
trix with ordered eigenvalues k01 P k
0
2 P . . .P k
0
m. Then
the original eigenvectors can be derived as
ui ¼ 1ﬃﬃﬃﬃﬃﬃﬃ
mk0i
p Xvi; for k
0
i 6¼ 0: ð6Þ
In fact, all nonzero eigenvalues k0i are same to those ki with
same order.
With this eigenvalue decomposition method, the num-
ber of components via PCA always is limited by the mini-
mum number between n and m.
2.2. NMF
Here we brieﬂy introduce the basic idea of NMF. Given
a data set in matrix form X 2 Rnmþ containing m samples
in n-dimension space, in which each of entry is nonnegative
(i.e. xij P 0 for all i; j), NMF is to ﬁnd an approximation as
X  BH ð7Þ
where B is an n d matrix and H a d  m matrix, and both
B;H are also nonnegative. Each column of B can be con-
sidered as a basis vector, and each column of H can be con-
sidered as a new feature vector corresponding to the
original data. See [4] for more information.
Basically, there exist two algorithms for completing the
decomposition via implementing multiplicative updates as
below [15]
bik  bik ðXH
TÞik
ðBHHTÞik
hkj  hkj
ðBTXÞkj
ðBTBHÞkj
ð8Þeiling Max/min Max–min Std.
6,000 5 500 N
6,000 5 500 300
6,000 N N N
6,000 5 500 N
6,000 4 500 N
6,000 5 500 N
6,000 5 500 500
N N 50
N N N
6,000 5 N N
6,000 3 100 N
Table 2
Cancer related human gene expression datasets
Dataset no. Dataset name Number of
Types Samples Selected genes
1 11_Tumors 11 174 5797
2 14_Tumors 26 308 5304
3 9_Tumors 9 60 5726
4 Brain_Tumor1 5 90 5905
5 Brain_Tumor2 4 50 5607
6 Leukemia1 2/3 72 5230
7 Leukemia2 3 72 5420
8 Lung_Cancer 5 203 3312
9 SRBCT 4 83 2308
10 Prostate_Tumor 2 102 3722
11 DLBCL 2 77 5431
The dataset 6 (leukemia1) can be divided into two or three types.
We consider the case of 2 groups for visualization and the case of 3 groups
for clustering.
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bik  bik
P
jhkj
xij
ðBHÞijP
jhkj
hkj  hkj
P
ibik
xij
ðBHÞijP
ibik
: ð9Þ
These multiplicative update rules can hold nonnegativity
easily with nonnegative initialization.
2.3. NMF vs PCA for reducing microarray data
Given a gene expression data, both NMF and PCA can
give a solution for dimension reduction. However there are
some diﬀerences between them:
 For nonnegative data, the result of NMF provides easer
interpretation than that of PCA [4]. In gene expression
data analysis, the basis of PCA, i.e. the principal compo-
nent containing negative values, has no physically inter-
pretable meaning. Such a basis can be called an
‘‘eigengene”. However, the basis of NMF holding non-
negativity, as called ‘‘metagene”, or ‘‘basis experiment”,
reﬂects the coexpressed levels of genes. See [11,9,13] for
more details.
 Microarray data always contains values from thousands
of genes ðnÞ in a few conditions ðmÞ, so n m holds.
For PCA, the number of principal components is limited
by the number of samples using the eigenvalue decom-–4 –2 0 2 4 6 8
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Fig. 1. Results of PCA vs NMF for reducing the leukemia data with 72 sampl
reduced data by NMF can clearly show this mistake while that by PCA canno
means basis experiment.position method; while for NMF, the number of learned
basis experiments is not so limited. It appears that NMF
can derived more features than samples for further clus-
tering analysis, and this may be why it got higher clus-
tering accuracy as shown in the experimental results.
 From computation point, we can see that PCA essen-
tially depends on empirical covariance matrix in which
a large number of samples are necessary. However, in0 1 2 3 4 5 6
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es in visualization. Sample 66 is mislabeled. However in 2-D display, the
t demonstrate the wrong. ‘PC’ stands for principal component and ‘BE’
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smaller than 100), much smaller than the number of
genes (in thousand scale).
 Finally, PCA is deterministic while NMF is stochastic;
many variants of NMF have been proposed; see refer-
ences in main text.
In summary, NMF appears to be more suitable for gene
expression sample analysis than PCA; and our experimen-
tal results on 11 real gene expression datasets also demon-
strate the superiority of NMF.
3. Experimental results
In this section we tested NMF for reducing microarray
data in visualization and clustering analysis via k-means
approach. In following experiments, the iteration number
for each run of NMF is set to 200 for convergence.
3.1. Datasets and preprocessing
We compared the discussed methods on 11 real cancer
related gene expression data sets. All datasets in Matlab
format are available from http://www.gems-system.org/;
see [16] and references therein for more information. It0 50 100 150 200
0.6
0.8
1
Dimensionality
Ac
ur
ac
y
dataset–1
0 100 2
0
0.5
1
Dimen
Ac
ur
ac
y
data
0 50 100 150
0.6
0.8
1
Dimensionality
Ac
ur
ac
y
dataset–4
0 20 4
0.7
0.8
0.9
1
Dimen
Ac
ur
ac
y
data
0 50 100
0.8
0.85
0.9
Dimensionality
Ac
ur
ac
y
dataset–7
0 50 100
0.6
0.8
1
Dimen
Ac
ur
ac
y
data
0 50 100 150
0.85
0.9
0.95
Dimensionality
Ac
ur
ac
y
dataset–10
0 50
0.7
0.8
0.9
Dimension
Ac
ur
ac
y
dataset–
Fig. 2. Results of PCA vs NMF for reducing microarrayshould be noted that all datasets but the SRBCT dataset,
are produced by oligonucleotide-based technology. The
dataset SRBCT was obtained via two-channel cDNA
platform.
In order to reduce computation complexity, we further
removed the genes which varied little across samples. See
Table 1 for the strategy of preprocessing. Based on the ori-
ginal preprocessing strategy of each dataset, we removed
genes which vary little across samples, so that the number
of genes remaining for each dataset is smaller than 6000.
For each dataset, expression levels below the value of Floor
were assigned a value of Floor, and those exceeding the
value of Ceiling were assigned a value of Ceiling. After this
ﬂoor and ceiling preprocessing, data is nonnegative and
can be used for both PCA and NMF. The maximum and
minimum values of a gene across samples were Max and
Min. Max/Min means the ratio of Max to Min, and
Max–Min means the diﬀerence of Max minus Min. Std.
means the standard deviation value of a gene across sam-
ples. Genes varying little across samples were removed
according to (at most) three indexes: Max/Min, Max–
Min, and Std. Furthermore, the number of groups, samples
and selected gene for each dataset is shown in Table 2. For
simplicity, we will use the dataset number instead of its
name for further discussion.00 300 400
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Table 3
Mean accuracy (%) over dimensionality on each real gene expression
dataset
Method 1 2 3 4 5 6 7 8 9 10 11
PCA 70 40 51 56 70 79 85 60 55 85 65
NMF 81 69 64 81 78 88 86 86 72 87 91
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Here we consider the leukemia1 dataset (No. 6) which
contains two groups: 47 ALL samples and 25 AML sam-
ples. In fact, there is a mislabeled sample (No. 66) should
be an ALL sample; see e.g. [17]. As shown in Fig. 1,
NMF can easily detect the wrong labeled sample 66 while
PCA cannot. In addition, the reduced data by NMF is
more clearly separated than that by PCA.
3.3. Clustering analysis through k-means
Next we considered cluster analysis on each dataset
using the reduced features, PCA scores or NMF scores.
We applied the standard k-means method with Matlab
via PCA and NMF. The distance measure for k-means is
squared Euclidean distance. For PCA, the values of dimen-
sionality for each dataset are set to f5; 10; 15; . . . ; ½m;mg
where m is the number of samples and ½m means the max-
imum integer which can be divided by 5 and smaller than
m; when ½m ¼ m, only one is used. For NMF, the reduced
dimensionality can be larger than the sample number, and
then the values of dimensionality for each dataset are set to
f5; 10; 15; . . . ; ½m; . . . ; ½mþ 20g. The average results over
100 repeated runs of k-means for each dimensionality are
shown in Fig. 2. And we also listed the mean accuracy over
dimensionality on each dataset in Table 3. We can see that
NMF almost always outperforms PCA, and this is consis-
tent with previous report in [3]. In addition, NMF can get
higher clustering accuracy for the situation with more fea-
tures than the number of samples.
4. Discussion and conclusions
We compared NMF and PCA for reducing microarray
data in visualization and clustering analysis through k-
means method. NMF has two obvious advantages over
PCA in microarray gene expression data analysis: (i)
NMF holds nonnegativity of gene expression data, and
(ii) NMF can derived features more than the number of
samples. Our results on one leukemia dataset show that
NMF can easily check the mislabeled sample via visualiza-
tion. And the clustering results via k-means approach on 11
real gene expression datasets demonstrate that NMF out-
performs PCA signiﬁcantly. Our results recommend that
NMF can be used as dimension reduction for visualization
and clustering analysis with contrast to PCA.Acknowledgments
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